Tobira Therapeutics, Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2013-01-17: Federal exemption Rule 506; Types of securities offered Equity; Notes are being converted into preferred stock; Date of first sale 2012-12-18; Total offering amount $50,780,221.
- 2012-05-21: Federal exemption Rule 506; Types of securities offered Equity; Debt; Notes convertible into preferred stock; Date of first sale 2012-05-03; Total offering amount $13,561,080.
- 2011-07-01: Federal exemption Rule 506; Types of securities offered Equity; Series D Preferred Stock; Date of first sale 2011-05-25; Total offering amount $11,599,999.
- 2011-07-01: Federal exemption Rule 506; Types of securities offered Equity; Series D Preferred Stock; Date of first sale 2010-03-30; Total offering amount $40,000,000.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2013-01-17 | Rule 506 | Equity; Notes are being converted into preferred stock | 2012-12-18 | $50,780,221 | $22,634,958 | $28,145,263 | 8 |
| 2012-05-21 | Rule 506 | Equity; Debt; Notes convertible into preferred stock | 2012-05-03 | $13,561,080 | $6,780,540 | $6,780,540 | 6 |
| 2011-07-01 | Rule 506 | Equity; Series D Preferred Stock | 2011-05-25 | $11,599,999 | $11,599,999 | $0 | 8 |
| 2011-07-01 D/A | Rule 506 | Equity; Series D Preferred Stock | 2010-03-30 | $40,000,000 | $40,000,000 | $0 | 8 |
| 2011-06-30 D/A | Rule 506 | Equity; Series D Preferred Stock | 2009-12-17 | $26,149,167 | $26,149,167 | $0 | 8 |
| 2010-01-05 | Rule 506 | Equity; Series D Preferred Stock | 2009-12-17 | $14,549,167 | $14,549,167 | $0 | 8 |